je.st
news
Tag: initiated
Alkane Energy Plc Coverage Initiated at Cantor Fitzgerald Europe
2015-05-25 22:40:30| Airlines - Topix.net
The firm set a "hold" rating and a GBX 20 price target on the stock. Cantor Fitzgerald Europe 's target price would suggest a potential downside of 12.09% from the company's current price.
Tags: europe
energy
coverage
initiated
Skyworks Solutions Coverage Initiated by Analysts at Goldman Sachs
2015-05-22 14:29:07| Semiconductors - Topix.net
In other Skyworks Solutions news, CEO David J. Aldrich sold 50,000 shares of the company's stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $100.44, for a total value of $5,022,000.00.
Tags: solutions
coverage
initiated
analysts
Whirlpool Coverage Initiated by Analysts at RBC Capital
2015-05-09 21:07:15| Appliances - Topix.net
The firm set an "outperform" rating and a $210.00 price target on the stock. RBC Capital's price objective points to a potential upside of 13.12% from the company's current price.
Tags: capital
coverage
initiated
analysts
Whirlpool (WHR) had coverage initiated by RBC Capital with an 'outperform' rating this morning.
2015-05-08 15:13:03| Appliances - Topix.net
Benton Harbor, MI-based Whirlpool Corporation is a manufacturer and marketer of major home appliances. The company manufactures products in 11 countries and markets products under brand names including Whirlpool, Maytag, KitchenAid, Jenn-Air, Amana, Bauknecht, Brastemp and Consul.
Tags: this
rating
capital
morning
Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone
2015-04-14 19:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. & AMES, Iowa rVSV-ZEBOV-GP (V920) Now Being Studied in Three Key Safety and Efficacy Clinical Trials KENILWORTH, N.J. & AMES, Iowa--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NewLink Genetics Corporation (NASDAQ: NLNK), confirmed today that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has been initiated in Sierra Leone. The vaccine candidate was originally developed by the Public Health Agency of Canadas National Microbiology Laboratory and licensed to NewLink Genetics in 2010. On Nov. Language: English Contact: Merck Media:Pam Eisele, 267-305-3558orImraan Munshi, 215-652-0059Investor:NewLink Genetics:Jack Henneman, 515-598-2561orMerck:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: NLNK Exchange: NASDAQ read more
Sites : [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] next »